Ireland
--:--IST
Recruiting Not applicable

Single Infrapubic Versus Bilateral Subinguinal Microsurgical Varicocelectomy

NCT07650955 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-06-08
Last updated
2026-06-16

Condition(s) studied

Bilateral VaricoceleMale Infertility

Investigational drug(s) / intervention(s)

Single Infrapubic Microsurgical Bilateral VaricocelectomyBilateral Subinguinal Microsurgical Varicocelectomy

Single Infrapubic Microsurgical Bilateral Varicocelectomy: Bilateral microsurgical varicocelectomy performed through a single midline infrapubic skin incision. The right and left spermatic cords will be approached sequentially through the same incision under microscopic or high-magnification surgical loupes with microsurgical capability. Dilated spermatic veins will be ligated while preserving the testicular artery or arteries, lymphatic vessels, vas deferens, and vasal vessels.

Bilateral Subinguinal Microsurgical Varicocelectomy: Conventional bilateral microsurgical varicocelectomy performed through two separate standard subinguinal incisions, one on each side. Each spermatic cord will be isolated at the subinguinal level under microscopic or high-magnification surgical loupes with microsurgical capability. Dilated spermatic veins will be ligated while preserving the testicular artery or arteries, lymphatic vessels, vas deferens, and vasal vessels.

Study summary

Bilateral varicocele is commonly treated by microsurgical varicocelectomy. The conventional bilateral subinguinal approach usually requires two separate skin incisions, one on each side. A single midline infrapubic approach may allow bilateral microsurgical repair through one incision and may reduce access-related morbidity.

This prospective randomized controlled trial will compare single infrapubic microsurgical bilateral varicocelectomy with conventional bilateral subinguinal microsurgical varicocelectomy in adult men with clinically palpable bilateral varicocele. The study will evaluate postoperative pain, analgesic requirement, time to return to normal daily activity, operative time, scar satisfaction, wound complications, recurrence, and other safety outcomes during follow-up.

Eligibility

Sex
MALE
Min age
18 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * Male patients aged 18 to 45 years. * Clinically palpable bilateral varicocele, grade II or grade III. * Diagnosis confirmed by color Doppler ultrasound. * Infertility for at least 12 months and/or abnormal semen analysis. * Female partner evaluation performed or planned to exclude major uncorrected female-factor infertility. * Patient fit for surgery and anesthesia. * Written informed consent provided by the participant. Exclusion Criteria: * Subclinical varicocele detected only by Doppler ultrasound. * Unilateral varicocele. * Recurrent varicocele after previous surgery, embolization, or sclerotherapy. * Previous inguinal, scrotal, pelvic, or penile surgery likely to distort surgical anatomy. * Associated inguinal hernia, hydrocele, spermatocele, epididymal cyst, or other scrotal condition requiring simultaneous surgery. * Azoospermia, especially suspected non-obstructive azoospermia. * Active urinary tract or genital infection. * Coagulopathy or anticoagulant therapy that cannot be safely interrupted. * Severe obesity, defined as body mass index greater than 40 kg/m², or any anatomical condition preventing safe exposure by either surgical approach. * Refusal to participate or inability to complete follow-up.

Primary outcome measure(s)

  • Postoperative Pain Score — 6 hours, 24 hours, and 7 days after surgery
    Postoperative pain will be assessed using the Visual Analog Scale. The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate worse postoperative pain.
  • Analgesic Requirement — During the first 7 postoperative days
    Analgesic requirement will be assessed by recording the total number and dose of analgesic tablets and/or injections consumed by the participant during the first 7 postoperative days. Higher analgesic use indicates greater postoperative analgesic requirement.
  • Time to Return to Normal Daily Activity — From surgery until return to normal daily activity, assessed up to 30 days after surgery
    Time to return to normal daily activity will be defined as the number of days from surgery until the participant resumes usual non-strenuous daily activities. A shorter time indicates faster postoperative recovery.
  • Total Operative Time — During surgery
    Total operative time will be defined as the time from skin incision to completion of skin closure, measured in minutes.

Trial sites (1)

FacilityCityRegionStatus
Department of Urology- Beni-Suef University Hospitals Banī Suwayf Beni Suweif Governorate Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07650955 on ClinicalTrials.gov ↗ ← All trials in Egypt